510(k) Report

FDA applicant

Biosensors International-USA

Newport Beach, CA3 decisions2003–20220 recalls

FDA records 3 decisions for Biosensors International-USA (Newport Beach, CA) from 2003 to 2022: 2 510(k) clearances and 1 original PMA approval. Most are in product codes DRS (Transducer, Blood-Pressure, Extravascular) and NIQ (Coronary Drug-Eluting Stent). Its devices cite 3 predicates, 0 of them its own earlier devices. No recall is linked to its devices.

FDA’s records also spell it “Biosensors International USA, Inc.”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Biosensors International-USA’s devices, and how often a recall has named them.

FDA decisions per year

1in 2022

2007: 12022: 1
2007high 1 (2007) · low 0 (2008)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Biosensors International-USA by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Biosensors International-USA’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Biosensors”

FDA records each applicant name separately; these may or may not be the same firm.